Linee guida per la prevenzione, la diagnosi e il trattamento dell ...
Linee guida per la prevenzione, la diagnosi e il trattamento dell ...
Linee guida per la prevenzione, la diagnosi e il trattamento dell ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
80. De<strong>la</strong>haye F, Rial MO, de Gevigney G, Ecochard R, De<strong>la</strong>ye J. A critical<br />
appraisal of the quality of the management of infective endocarditis.<br />
J Am Coll Cardiol 1999; 33: 788-93.<br />
81. Baron EJ, Scott JD, Tompkins LS. Prolonged incubation and extensive<br />
subculturing do not increase recovery of clinically significant<br />
microorganisms from standard automated blood cultures. Clin Infect<br />
Dis 2005; 41: 1677-80.<br />
82. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis<br />
of 63 cases presenting over 25 years. Heart 2003; 89: 258-62.<br />
83. Brouqui P, Raoult D. New insight into the <strong>diagnosi</strong>s of fastidious<br />
bacterial endocarditis. FEMS Immunol Med Microbiol 2006; 47: 1-13.<br />
84. Watkin RW, Lang S, Lambert PA, Littler WA, Elliott TS. The serological<br />
<strong>diagnosi</strong>s of staphylococcal infective endocarditis. J Infect<br />
2006; 53: 301-7.<br />
85. M<strong>il</strong><strong>la</strong>r BC, Moore JE. Current trends in the molecu<strong>la</strong>r <strong>diagnosi</strong>s of infective<br />
endocarditis. Eur J Clin Microbiol Infect Dis 2004; 23: 353-65.<br />
86. Breitkopf C, Hammel D, Scheld HH, Peters G, Becker K. Impact of a<br />
molecu<strong>la</strong>r approach to improve the microbiological <strong>diagnosi</strong>s of<br />
infective heart valve endocarditis. Circu<strong>la</strong>tion 2005; 111: 1415-21.<br />
87. Rovery C, Greub G, Lepidi H, Casalta JP, Habib G, Col<strong>la</strong>rt F, Raoult<br />
D. PCR detection of bacteria on cardiac valves of patients with<br />
treated bacterial endocarditis. J Clin Microbiol 2005; 43: 163-7.<br />
88. Branger S, Casalta JP, Habib G, Col<strong>la</strong>rd F, Raoult D. Streptococcus<br />
pneumoniae endocarditis: <strong>per</strong>sistence of DNA on heart valve material<br />
7 years after infectious episode. J Clin Microbiol 2003; 41:<br />
4435-7.<br />
89. Fenol<strong>la</strong>r F, Raoult D. Molecu<strong>la</strong>r <strong>diagnosi</strong>s of bloodstream infections<br />
caused by non-cultivable bacteria. Int J Antimicrob Agents<br />
2007; 30 (Suppl 1): S7-S15.<br />
90. Fenol<strong>la</strong>r F, Goncalves A, Esterni B, Azza S, Habib G, Borg JP, Raoult<br />
D. A serum protein signature with high diagnostic value in bacterial<br />
endocarditis: results from a study based on surface-enhanced<br />
<strong>la</strong>ser desorption/ionization time-of-flight mass spectrometry. J Infect<br />
Dis 2006; 194: 1356-66.<br />
91. M<strong>il</strong><strong>la</strong>r B, Moore J, Mallon P, Xu J, Crowe M, McClurg R, Raoult D,<br />
Earle J, Hone R, Murphy P. Molecu<strong>la</strong>r <strong>diagnosi</strong>s of infective endocarditis<br />
- a new Duke’s criterion. Scand J Infect Dis 2001; 33: 673-80.<br />
92. Durack DT, Lukes AS, Bright DK. New criteria for <strong>diagnosi</strong>s of infective<br />
endocarditis: ut<strong>il</strong>ization of specific echocardiographic findings.<br />
Duke Endocarditis Service. Am J Med 1994; 96: 200-9.<br />
93. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification<br />
of the diagnostic criteria proposed by the Duke Endocarditis Service<br />
to <strong>per</strong>mit improved <strong>diagnosi</strong>s of Q fever endocarditis. Am J<br />
Med 1996; 100: 629-33.<br />
94. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T,<br />
Corey GR. Proposed modifications to the Duke criteria for the <strong>diagnosi</strong>s<br />
of infective endocarditis. Clin Infect Dis 2000; 30: 633-8.<br />
95. Prendergast BD. Diagnostic criteria and problems in infective endocarditis.<br />
Heart 2004; 90: 611-3.<br />
96. San Roman JA, Lopez J, Vi<strong>la</strong>costa I, Luaces M, Sarria C, Rev<strong>il</strong><strong>la</strong> A,<br />
Ronderos R, Stoermann W, Gomez I, Fernandez-Av<strong>il</strong>es F. Prognostic<br />
stratification of patients with left-sided endocarditis determined<br />
at admission. Am J Med 2007; 120: 369e1-e7.<br />
97. Chu VH, Cabell CH, Benjamin DK Jr, Kuniholm EF, Fowler VG Jr, Engemann<br />
J, Sexton DJ, Corey GR, Wang A. Early predictors of in-hospital<br />
death in infective endocarditis. Circu<strong>la</strong>tion 2004; 109: 1745-9.<br />
98. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ.<br />
Complicated left-sided native valve endocarditis in adults: risk c<strong>la</strong>ssification<br />
for mortality. JAMA 2003; 289: 1933-40.<br />
99. Mansur AJ, Grinberg M, Cardoso RH, da Luz PL, Bellotti G, P<strong>il</strong>eggi<br />
F. Determinants of prognosis in 300 episodes of infective endocarditis.<br />
Thorac Cardiovasc Surg 1996; 44: 2-10.<br />
100. Wal<strong>la</strong>ce SM, Walton BI, Kharbanda RK, Hardy R, W<strong>il</strong>son AP, Swanton<br />
RH. Mortality from infective endocarditis: clinical predictors of<br />
outcome. Heart 2002; 88: 53-60.<br />
101. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Se<strong>il</strong>er C. Infective<br />
endocarditis: determinants of long term outcome. Heart<br />
2002; 88: 61-6.<br />
e37<br />
<strong>Linee</strong> <strong>guida</strong> ESC<br />
102. De<strong>la</strong>haye F, Al<strong>la</strong> F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin<br />
F, Selton-Suty C, Vandenesch F, Vernet V, Hoen B. In-hospital<br />
mortality of infective endocarditis: prognostic factors and evolution<br />
over an 8-year <strong>per</strong>iod. Scand J Infect Dis 2007; 39: 849-57.<br />
103. Duval X, Al<strong>la</strong> F, Doco-Lecompte T, Le Moing V, De<strong>la</strong>haye F, Mainardi<br />
JL, Plesiat P, Ce<strong>la</strong>rd M, Hoen B, Leport C. Diabetes mellitus and<br />
infective endocarditis: the insulin factor in patient morbidity and<br />
mortality. Eur Heart J 2007; 28: 59-64.<br />
104. Jassal DS, Nei<strong>la</strong>n TG, Pradhan AD, Lynch KE, V<strong>la</strong>hakes G, Agnihotri<br />
AK, Picard MH. Surgical management of infective endocarditis:<br />
early predictors of short-term morbidity and mortality. Ann Thorac<br />
Surg 2006; 82: 524-9.<br />
105. Cast<strong>il</strong>lo JC, Anguita MP, Ramirez A, S<strong>il</strong>es JR, Torres F, Mesa D, Franco<br />
M, Munoz I, Concha M, Valles F. Long term outcome of infective<br />
endocarditis in patients who were not drug addicts: a 10 year<br />
study. Heart 2000; 83: 525-30.<br />
106. Wang A, Athan E, Pappas PA, Fowler VG Jr, O<strong>la</strong>ison L, Pare C, Almirante<br />
B, Munoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL,<br />
Selton-Suty C, Jones SB, Casabe J, Morris A, Corey GR, Cabell CH.<br />
Contemporary clinical prof<strong>il</strong>e and outcome of prosthetic valve endocarditis.<br />
JAMA 2007; 297: 1354-61.<br />
107. Rev<strong>il</strong><strong>la</strong> A, Lopez J, Vi<strong>la</strong>costa I, V<strong>il</strong><strong>la</strong>corta E, Rol<strong>la</strong>n MJ, Echevarria JR,<br />
Carrascal Y, Di Stefano S, Fulquet E, Rodriguez E, Fiz L, San Roman<br />
JA. Clinical and prognostic prof<strong>il</strong>e of patients with infective endocarditis<br />
who need urgent surgery. Eur Heart J 2007; 28: 65-71.<br />
108. Durack DT, Pelletier LL, Petersdorf RG. Chemotherapy of ex<strong>per</strong>imental<br />
streptococcal endocarditis. II. Synergism between penic<strong>il</strong>lin<br />
and streptomycin against penic<strong>il</strong>lin-sensitive streptococci. J Clin Invest<br />
1974; 53: 829-33.<br />
109. W<strong>il</strong>son WR, Geraci JE, W<strong>il</strong>kowske CJ, Washington JA 2nd. Shortterm<br />
intramuscu<strong>la</strong>r therapy with procaine penic<strong>il</strong>lin plus streptomycin<br />
for infective endocarditis due to viridans streptococci. Circu<strong>la</strong>tion<br />
1978; 57: 1158-61.<br />
109a.Morris AJ, Drinkovic D, Pottumarthy S, MacCulloch D, Kerr AR,<br />
West T. Bacteriological outcome after valve surgery for active infective<br />
endocarditis: implications for duration of treatment after<br />
surgery. Clin Infect Dis 2005; 41: 187-94.<br />
110. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Guidelines<br />
for the antibiotic treatment of endocarditis in adults: report of the<br />
Working Party of the British Society for Antimicrobial Chemotherapy.<br />
J Antimicrob Chemother 2004; 54: 971-81.<br />
111. Westling K, Aufwerber E, Ekdahl C, Friman G, Gardlund B, Ju<strong>la</strong>nder<br />
I, O<strong>la</strong>ison L, Olesund C, Rundstrom H, Snygg-Martin U, Thalme<br />
A, Werner M, Hogevik H. Swedish guidelines for <strong>diagnosi</strong>s and<br />
treatment of infective endocarditis. Scand J Infect Dis 2007; 39:<br />
929-46.<br />
112. Nico<strong>la</strong>u DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW,<br />
Quint<strong>il</strong>iani R. Ex<strong>per</strong>ience with a once-da<strong>il</strong>y aminoglycoside program<br />
administered to 2184 adult patients. Antimicrob Agents<br />
Chemother 1995; 39: 650-5.<br />
113. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis<br />
with a single da<strong>il</strong>y dose of ceftriaxone and net<strong>il</strong>micin for<br />
14 days: a prospective multicenter study. Clin Infect Dis 1995; 21:<br />
1406-10.<br />
114. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A. Treatment of<br />
streptococcal endocarditis with a single da<strong>il</strong>y dose of ceftriaxone<br />
sodium for 4 weeks. Efficacy and outpatient treatment feasib<strong>il</strong>ity.<br />
JAMA 1992; 267: 264-7.<br />
115. Sexton DJ, Tenenbaum MJ, W<strong>il</strong>son WR, Steckelberg JM, Tice AD,<br />
G<strong>il</strong>bert D, Dismukes W, Drew RH, Durack DT. Ceftriaxone once da<strong>il</strong>y<br />
for four weeks compared with ceftriaxone plus gentamicin once<br />
da<strong>il</strong>y for two weeks for treatment of endocarditis due to penic<strong>il</strong>lin-susceptible<br />
streptococci. Endocarditis Treatment Consortium<br />
Group. Clin Infect Dis 1998; 27: 1470-4.<br />
116. Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul<br />
H, Bouvet A, Pocidalo JJ, Carbon C. Evaluation of antibiotic<br />
diffusion into cardiac vegetations by quantitative autoradiography.<br />
J Infect Dis 1989; 159: 938-44.